The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

“It’s not OK for them to dismiss it like that.” Uterine is the only cancer for which survival has fallen in the past four ...

Endometrial, or uterine, cancer affects more than 60,000 women in the U.S. each year. It is one of the few cancers in which incidence is increasing. Survival for early-stage endometrial cancer ...

Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.

Cancer mortality rates have decreased by 34% overall, but incidence rates for women of all ages continue to rise, according to a new report from the American Cancer Society.

Uterine cancer, which often begins in the lining—or endometrium—of the uterus, is the most common cancer of the female reproductive system and usually occurs in people over age 55. Learn more ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

Individuals in food deserts are more likely to be diagnosed with advanced-stage cervical and uterine cancers. Food insecurity correlates with higher mortality rates for cervical, uterine, and ovarian ...

European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...